Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06236815 · ClinicalTrials.gov registry record · Early Phase 1
High Confusion: Cannabis & Driving
A Early Phase 1 study, sponsored by University of Wisconsin, Madison.
- Completed
- Registry status
- Early Phase 1
- Development phase
- 5
- Enrollment target
NCT06236815 is a Early Phase 1 study that has completed, run by University of Wisconsin, Madison. The registered enrollment target is 5 participants.
The verdict
NCT06236815, a Early Phase 1 study, has completed, sponsored by University of Wisconsin, Madison.
- COMPLETED
- Registry status
- Early Phase 1
- Development phase
- 5 participants
- Enrollment target
Study Summary
This study is being done to assess the feasibility of administrating Δ9-THC and Δ8-THC isolates and simultaneously adopting several data harmonization measures to generate uniquely translatable data. This project aims to (1) evaluate the feasibility and acceptability of administering ∆9-THC and Δ8-THC isolates using standardized cannabis dosing units to quantify ∆9-THC and Δ8-THC pharmacokinetics; and (2) evaluate the feasibility and acceptability of adopting standardized impairment detection methods and driving performance definitions and measures on quantifying ∆9-THC and Δ8-THC driving impairment compared to a placebo.
Interventions
- DRUG Placebo
- DRUG Delta-9-THC
- DRUG Delta-8-THC
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5 participants |
| Start Date | 2025-01-25 |
| Est. Completion | 2025-09-16 |
| Phase | Early Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06236815
The ClinicalTrials.gov registry entry for NCT06236815 describes a study currently listed as completed, categorized as Early Phase 1. The registered enrollment target is 5 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Wisconsin, Madison, which has 1,039 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Placebo is the first listed.
NCT06236815 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06236815 about?
NCT06236815 is a clinical study titled "High Confusion: Cannabis & Driving". This study is being done to assess the feasibility of administrating Δ9-THC and Δ8-THC isolates and simultaneously adopting several data harmonization measures to generate uniquely translatable data. This project aims to (1) evaluate the feasibility and acceptability of administering ∆9-THC and Δ8-T...
What is the current status of trial NCT06236815?
This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 5 participants. The study started on 2025-01-25. Estimated completion is 2025-09-16.
What interventions are being tested in trial NCT06236815?
The interventions under investigation include: Placebo (DRUG), Delta-9-THC (DRUG), Delta-8-THC (DRUG).
Who is sponsoring clinical trial NCT06236815?
This trial is sponsored by University of Wisconsin, Madison, which has 1,039 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.